WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Osteoporosis Efficacy Criteria v2, vertebral height is collected per each vertebra in projections Radiograph projections, The proportion of patients with at least one vertebral fracture calculates Vertebral fracture, Single-energy photon absorptiometry (SPA) expressed as Absorption of a monochromatic photon beam by bone mineral in vivo, symptomatic where symptoms include pain, Vertebral fracture can be symptomatic, Blood for Serum biomarkers, Therapeutic Efficacy Point is the intersection of Physiological Process, FDA Efficacy Points for Osteoporosis include Bone Mineral Density (BMD), Bone Mineral Density (BMD) measured by methods of Biochemical markers of bone turnover, serum c-telopeptides (CTx) to determine bone resorption, Observation or Assessment is used to monitor the effectiveness of Therapeutic Intervention, Therapeutic Efficacy Point is the intersection of Therapeutic Intervention, Patient's Medical History includes Concomitant Medications, FDA Efficacy Points for Osteoporosis include evaluation of risk factors in Patient's Medical History, Bone Mineral Density (BMD) measured at Time Points, Bone Mineral Density (BMD) measured as T score, Non-vertebral fracture diagnosis confirmed with Radiographic Test, asymptomatic diagnosed with Radiographic Test, Bone Mineral Density (BMD) measured as BMD scale, Instance of concepts (e.g. 14 days, 10 mL/min) are denoted by solid square-edged light yellow rectangle